C26H34FNO5
Neat
459.5
cerivastatin; 145599-86-6; Lipobay; Cerivastatina; AM91H2KS67; CHEBI:3558; (3R, 5S, 6E)-7-(4-(4-Fluorophenyl)-5-(methoxymethyl)-2, 6-bis(1-methylethyl)-3-pyridinyl)-3, 5-dihydroxy-6-heptenoic acid; (3R, 5S, 6E)-7-(4-(p-Fluorophenyl)-2, 6-diisopropyl-5-(methoxymethyl)-3-pyridyl)-3, 5-dihydroxy-6-heptenoic acid; DTXSID9022786; (3R, 5S, 6E)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2, 6-di(propan-2-yl)pyridin-3-yl]-3, 5-dihydroxyhept-6-enoic acid; (E, 3R, 5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2, 6-di(propan-2-yl)pyridin-3-yl]-3, 5-dihydroxyhept-6-enoic acid; 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2, 6-bis(1-methylethyl)-3-pyridinyl)-3, 5-dihydroxy-, (S-(R*, S*-(E)))-; cerivastatinum; (3R, 5S, 6E)-7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2, 6-di(propan-2-yl)pyridin-3-yl)-3, 5-dihydroxyhept-6-enoic acid; (E, 3R, 5S)-7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2, 6-di(propan-2-yl)pyridin-3-yl)-3 and 5-dihydroxyhept-6-enoic acid; RefChem:575215; GlyTouCan:G66624UT; DTXCID402786; C10AA06; G66624UT
(E, 3R, 5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2, 6-di(propan-2-yl)-3-pyridinyl]-3 and 5-dihydroxyhept-6-enoic acid
InChI=1S/C26H34FNO5/c1-15(2)25-21(11-10-19(29)12-20(30)13-23(31)32)24(17-6-8-18(27)9-7-17)22(14-33-5)26(28-25)16(3)4/h6-11,15-16,19-20,29-30H,12-14H2,1-5H3,(H,31,32)/b11-10+/t19-,20-/m1/s1